Literature DB >> 3031208

Involvement of both opiate and catecholaminergic receptors of ventromedial hypothalamus in the locomotor stimulant action of thyrotropin-releasing hormone.

L S Lin, W T Chiu, C J Shih, M T Lin.   

Abstract

To explore the mode of the locomotor stimulant action of thyrotropin-releasing hormone (TRH), rats with or without administration of opiate or catecholaminergic receptor antagonists were infused with TRH through previously implanted hypothalamic cannula. Administration of TRH, but not the normal saline or TSH, into the ventromedial hypothalamus caused an enhancement in both the gross movements (including stimulation of forward locomotion, head and body rearing) and fine movements (including increased grooming and head swaying). The locomotor stimulant action provoked by TRH was antagonized by pretreatment of ventromedial hypothalamus with either an alpha-adrenergic receptor antagonist (yohimbine), a dopaminergic receptor antagonist (haloperidol) or an opiate receptor antagonist (naloxone), but not with a beta-adrenergic receptor antagonist (propranolol). The results indicate that all the adrenergic, dopaminergic and opiate receptors in the ventromedial hypothalamus are involved in the TRH-induced hyperactivity in the rat.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031208     DOI: 10.1007/BF02098499

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  12 in total

1.  Thyrotrophin-releasing hormone and shaking behaviour in rat.

Authors:  E Wei; S Sigel; H Loh; E L Way
Journal:  Nature       Date:  1975-02-27       Impact factor: 49.962

2.  Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists.

Authors:  E T Iwamoto
Journal:  J Pharmacol Exp Ther       Date:  1981-05       Impact factor: 4.030

3.  Decreased locomotor activity and attenuation of amphetamine hyperactivity with intraventricular infusion of serotonin in the rat.

Authors:  J D Warbritton; R M Stewart; R J Baldessarini
Journal:  Brain Res       Date:  1978-03-24       Impact factor: 3.252

4.  Mesolimbic involvement in the locomotor stimulant action of thyrotropin-releasing hormone (TRH) in rats.

Authors:  M Miyamoto; Y Nagawa
Journal:  Eur J Pharmacol       Date:  1977-07-15       Impact factor: 4.432

5.  Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.

Authors:  G R Breese; B R Cooper; R A Mueller
Journal:  Br J Pharmacol       Date:  1974-10       Impact factor: 8.739

6.  Thyrotropin-releasing hormone and amphetamine produce different patterns of behavioral excitation in rats.

Authors:  G N Ervin; S A Schmitz; C B Nemeroff; A J Prange
Journal:  Eur J Pharmacol       Date:  1981-06-10       Impact factor: 4.432

7.  Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways.

Authors:  M A Geyer; A Puerto; D B Menkes; D S Segal; A J Mandell
Journal:  Brain Res       Date:  1976-04-23       Impact factor: 3.252

8.  Hypothalamic involvement in the locomotor stimulant or satiety action of thyrotropin-releasing hormone and amphetamine.

Authors:  L R Shian; M H Wu; M T Lin; L T Ho
Journal:  Pharmacology       Date:  1985       Impact factor: 2.547

9.  Involvement of both opiate and catecholaminergic receptors in the behavioural excitation provoked by thyrotropin-releasing hormone: comparisons with amphetamine.

Authors:  M T Lin; H K Chan; C F Chen; G W Teh
Journal:  Neuropharmacology       Date:  1983-04       Impact factor: 5.250

10.  Thyrotropin-releasing hormone-induced hyperglycemia: possible involvement of cholinergic receptors in the lateral hypothalamus.

Authors:  D C Shen; M T Lin; L R Shian
Journal:  Neuroendocrinology       Date:  1985-12       Impact factor: 4.914

View more
  2 in total

Review 1.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

2.  Thyrotropin-releasing hormone increases behavioral arousal through modulation of hypocretin/orexin neurons.

Authors:  Junko Hara; Dmitry Gerashchenko; Jonathan P Wisor; Takeshi Sakurai; Xinmin Xie; Thomas S Kilduff
Journal:  J Neurosci       Date:  2009-03-25       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.